Stem Cell Inc.

CIK:0001828613|SEC Filings
v3.23.3
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
CONDENSED STATEMENTS OF OPERATIONS (Unaudited)        
REVENUES $ 0 $ 0 $ 0 $ 0
Total 0 0 0 0
Operating Expenses:        
General and administrative 2,625 3,350 9,672 8,934
Professional Fees 1,800 24,000 27,900 56,500
Total Expenses 4,425 27,350 37,572 65,434
Net Loss Before Tax (4,425) (27,350) (37,572) (65,434)
Interest Expense 810 600 2,010 600
Provision for Income Tax 0 0 0 0
Net Loss $ (5,235) $ (27,950) $ (39,582) $ (66,034)
Net loss per share - basic and fully diluted $ (0.0003) $ (0.0014) $ (0.0020) $ (0.0033)
Weighted average number of shares* outstanding: 20,155,300 20,155,300 20,155,300 20,155,300